跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe - TGA Drug Approval Details
Approvals
/
TGA
/
HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe
Approved
STANDARD
HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
212d58556e5ac841
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
212d58556e5ac841
Product Name
HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe
Artg Id
215536
Artg Name
HEXAXIM DTPa-hepB-IPV-Hib Suspension for injection in pre-filled syringe
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2014-09-11
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/8b592adf4835621bff21ad961c25e80f.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/467d210daa16942c64da2730c5bcf6c3.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
212d58556e5ac841
Type
Standard
Back to TGA Approvals